As of the latest Form 4 filed Jul 9, 2026.
What Clover Health Investments Corp insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 33 most recent filings for CLOV.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | 2026-07-08 | Reynoso Jamie L. CEO, Medicare Advantage | SSale | −2.38K | $4.68 | $11.2K | Yes (planned) | Form 4 ↗ |
| 2026-07-06 | 2026-07-06 | Reynoso Jamie L. CEO, Medicare Advantage | SSale | −6.23K | $5.26 | $32.8K | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-07-01 | Toy Andrew Chief Executive Officer | SSale | −313K | $5.32 | $1.67M | Yes (planned) | Form 4 ↗ |
| 2026-06-18 | 2026-06-17 | Reynoso Jamie L. CEO, Medicare Advantage | SSale | −2.36K | $4.78 | $11.3K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER | SSale | −12.1K | $4.86 | $58.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Reynoso Jamie L. CEO, Medicare Advantage | SSale | −6.35K | $4.61 | $29.3K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Soares Karen Chief Legal Officer | SSale | −4.68K | $4.61 | $21.6K | Yes (planned) | Form 4 ↗ |
| 2026-06-11 | 2026-06-11 | Reynoso Jamie L. CEO, Medicare Advantage | SSale | −7.29K | $4.91 | $35.8K | Yes (planned) | Form 4 ↗ |
| 2026-05-28 | 2026-05-28 | Wai Conrad CEO, Counterpart Health | SSale | −220K | $3.99 | $879K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Edwards Carladenise Armbrister Director | SSale | −67.2K | $3.42 | $230K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-16 | THORNTON JOSEPH CLAY Interim CFO | FTax | −16.9K | $3.47 | $58.8K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-13 | Priest Brady Patrick CEO of Clover Care Services | SSale | −98.0K | $3.52 | $345K | No | Form 4 ↗ |
| 2026-05-12 | 2026-05-08 | Toy Andrew Chief Executive Officer | FTax | −85.7K | $2.82 | $242K | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-18 | Priest Brady Patrick CEO of Clover Care Services | FTax | −36.1K | $2.19 | $79.1K | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | Soares Karen Chief Legal Officer | FTax | −10.2K | $2.04 | $20.7K | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | Wai Conrad CEO, Counterpart Health | FTax | −23.5K | $2.04 | $47.9K | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | Priest Brady Patrick CEO of Clover Care Services | FTax | −15.5K | $2.04 | $31.6K | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | Reynoso Jamie L. CEO, Medicare Advantage | FTax | −12.7K | $2.04 | $25.9K | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | Toy Andrew Chief Executive Officer | FTax | −60.8K | $2.04 | $124K | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | THORNTON JOSEPH CLAY Interim CFO | FTax | −4.16K | $2.04 | $8.48K | No | Form 4 ↗ |
| 2026-04-07 | 2026-04-03 | Reynoso Jamie L. CEO, Medicare Advantage | FTax | −6.20K | $1.72 | $10.7K | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Soares Karen Chief Legal Officer | AAward | +383K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Wai Conrad CEO, Counterpart Health | AAward | +268K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Priest Brady Patrick CEO of Clover Care Services | AAward | +191K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Reynoso Jamie L. CEO, Medicare Advantage | AAward | +159K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Toy Andrew Chief Executive Officer | FTax | −310K | $1.76 | $545K | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Toy Andrew, Chief Executive Officer | AAward | +956K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-18 | Reynoso Jamie L. CEO, Medicare Advantage | SSale | −5.83K | $1.91 | $11.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-17 | 2026-03-15 | Soares Karen General Counsel & Secretary | FTax | −4.53K | $1.98 | $8.97K | No | Form 4 ↗ |
| 2026-03-17 | 2026-03-15 | Reynoso Jamie L. CEO, Medicare Advantage | FTax | −6.19K | $1.98 | $12.3K | No | Form 4 ↗ |
| 2026-03-17 | 2026-03-14 | Wai Conrad CEO, Counterpart Health | FTax | −100K | $1.98 | $198K | No | Form 4 ↗ |
| 2026-03-17 | 2026-03-14 | Reynoso Jamie L. CEO, Medicare Advantage | FTax | −8.95K | $1.98 | $17.7K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Priest Brady Patrick CEO of Home Care | SSale | −175K | $2.17 | $380K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CLOV’s full analysis or the market-wide insider trading feed. The tabs above jump to CLOV’s other SEC data.
Source: SEC Form 4 filings for CLOV, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.